2011: Heterogeneity in benefit assessments

Presentations (German):

  •  Introduction
  •  Pooling of studies with different characteristics
  •  IQWiG's biometric approach to heterogeneity - current status and outlook
  •  Measures on heterogeneity in meta-analyses - critical discussion
  •  Examination and handling of heteregeneity in benefit assessments - an outline of the problem
  •  Meta-analysis of rare adverse drug effects from heterogeneous clinical trials
  •  Discussion